These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26319228)

  • 1. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.
    Gibney M; Xue Z; Swinney M; Bialonczyk D; Hirsch L
    Diabetes Technol Ther; 2016 Mar; 18(3):136-43. PubMed ID: 26701357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.
    Rini CJ; McVey E; Sutter D; Keith S; Kurth HJ; Nosek L; Kapitza C; Rebrin K; Hirsch L; Pettis RJ
    Drug Deliv Transl Res; 2015 Aug; 5(4):332-45. PubMed ID: 26037035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
    Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
    Pettis RJ; Ginsberg B; Hirsch L; Sutter D; Keith S; McVey E; Harvey NG; Hompesch M; Nosek L; Kapitza C; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):435-42. PubMed ID: 21355718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.
    McVey E; Hirsch L; Sutter DE; Kapitza C; Dellweg S; Clair J; Rebrin K; Judge K; Pettis RJ
    J Diabetes Sci Technol; 2012 Jul; 6(4):743-54. PubMed ID: 22920798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    J Diabetes Sci Technol; 2018 May; 12(3):608-613. PubMed ID: 29284290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
    Borot S; Franc S; Cristante J; Penfornis A; Benhamou PY; Guerci B; Hanaire H; Renard E; Reznik Y; Simon C; Charpentier G;
    J Diabetes Sci Technol; 2014 Nov; 8(6):1133-41. PubMed ID: 25079676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
    Regittnig W; Urschitz M; Lehki B; Wolf M; Kojzar H; Mader JK; Ellmerer M; Pieber TR
    Diabetes Technol Ther; 2019 Jan; 21(1):44-50. PubMed ID: 30620643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
    Norman JJ; Brown MR; Raviele NA; Prausnitz MR; Felner EI
    Pediatr Diabetes; 2013 Sep; 14(6):459-65. PubMed ID: 23517449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study.
    Naik S; Kerr D; Begley J; Morton J
    Diabetes Technol Ther; 2012 Nov; 14(11):1018-22. PubMed ID: 23101952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems.
    Freckmann G; Kamecke U; Waldenmaier D; Haug C; Ziegler R
    Diabetes Technol Ther; 2019 Apr; 21(4):201-208. PubMed ID: 30901232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.
    Højbjerre L; Skov-Jensen C; Kaastrup P; Pedersen PE; Stallknecht B
    Diabetes Technol Ther; 2009 May; 11(5):301-6. PubMed ID: 19425878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
    Pfützner A; Sachsenheimer D; Grenningloh M; Heschel M; Walther-Johannesen L; Gharabli R; Klonoff D
    J Diabetes Sci Technol; 2015 Sep; 9(6):1292-8. PubMed ID: 26341262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of infusion set function: steel versus teflon.
    Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue.
    Eisler G; Kastner JR; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Thakur ML; Strasma P; Joseph JI
    BMJ Open Diabetes Res Care; 2019; 7(1):e000881. PubMed ID: 31875136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient management of long-term continuous subcutaneous insulin infusion.
    Johansson UB; Adamson U; Lins PE; Wredling R
    J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.